Chronic Obstructive Pulmonary Disease and Hepatitis C
Chronic obstructive pulmonary disease (COPD) is a preventable, treatable disease with significant extrapulmonary manifestations that could affect negatively its course in some patients. Hepatitis C virus infection (HCV), on the other hand, is associated with a number of extrahepatic manifestations....
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Pensoft Publishers
2017-06-01
|
Series: | Folia Medica |
Subjects: | |
Online Access: | http://www.degruyter.com/view/j/folmed.2017.59.issue-2/folmed-2017-0018/folmed-2017-0018.xml?format=INT |
id |
doaj-0f346382a2304815aa116d461cdf62df |
---|---|
record_format |
Article |
spelling |
doaj-0f346382a2304815aa116d461cdf62df2020-11-24T21:19:27ZengPensoft PublishersFolia Medica 1314-21432017-06-0159213213810.1515/folmed-2017-0018folmed-2017-0018Chronic Obstructive Pulmonary Disease and Hepatitis CMekov Evgeni V.0Petkov Rosen E.1Kostadinov Dimitar T.2Antonov Krasimir A.3Jelev Deian T.4Clinical Center for Pulmonary Diseases, St. Sofia Hospital for Pulmonary Diseases, Medical University of Sofia, Sofia, BulgariaClinical Center for Pulmonary Diseases, St. Sofia Hospital for Pulmonary Diseases, Medical University of Sofia, Sofia, BulgariaClinical Center for Pulmonary Diseases, St. Sofia Hospital for Pulmonary Diseases, Medical University of Sofia, Sofia, BulgariaClinic of Gastroenterology, St. Ivan Rilski University Hospital, Medical University of Sofia, Sofia, BulgariaClinic of Gastroenterology, St. Ivan Rilski University Hospital, Medical University of Sofia, Sofia, BulgariaChronic obstructive pulmonary disease (COPD) is a preventable, treatable disease with significant extrapulmonary manifestations that could affect negatively its course in some patients. Hepatitis C virus infection (HCV), on the other hand, is associated with a number of extrahepatic manifestations. COPD patients have increased prevalence of HCV and patients with HCV, especially older ones, have increased prevalence and faster progression of COPD. HCV infection exerts long-term effects on lung tissue and is an additional risk factor for the development of COPD. The presence of HCV is associated with an accelerated loss of lung function in COPD patients, especially in current smokers. COPD could represent extrahepatic manifestation associated with HCV infection. The aim of this article was to review the literature on prevalence of HCV in COPD and vice versa, pathogenetic link and the consequences of their mutual existence.http://www.degruyter.com/view/j/folmed.2017.59.issue-2/folmed-2017-0018/folmed-2017-0018.xml?format=INTCOPDhepatitis CHCVcomorbidity |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mekov Evgeni V. Petkov Rosen E. Kostadinov Dimitar T. Antonov Krasimir A. Jelev Deian T. |
spellingShingle |
Mekov Evgeni V. Petkov Rosen E. Kostadinov Dimitar T. Antonov Krasimir A. Jelev Deian T. Chronic Obstructive Pulmonary Disease and Hepatitis C Folia Medica COPD hepatitis C HCV comorbidity |
author_facet |
Mekov Evgeni V. Petkov Rosen E. Kostadinov Dimitar T. Antonov Krasimir A. Jelev Deian T. |
author_sort |
Mekov Evgeni V. |
title |
Chronic Obstructive Pulmonary Disease and Hepatitis C |
title_short |
Chronic Obstructive Pulmonary Disease and Hepatitis C |
title_full |
Chronic Obstructive Pulmonary Disease and Hepatitis C |
title_fullStr |
Chronic Obstructive Pulmonary Disease and Hepatitis C |
title_full_unstemmed |
Chronic Obstructive Pulmonary Disease and Hepatitis C |
title_sort |
chronic obstructive pulmonary disease and hepatitis c |
publisher |
Pensoft Publishers |
series |
Folia Medica |
issn |
1314-2143 |
publishDate |
2017-06-01 |
description |
Chronic obstructive pulmonary disease (COPD) is a preventable, treatable disease with significant extrapulmonary manifestations that could affect negatively its course in some patients. Hepatitis C virus infection (HCV), on the other hand, is associated with a number of extrahepatic manifestations. COPD patients have increased prevalence of HCV and patients with HCV, especially older ones, have increased prevalence and faster progression of COPD. HCV infection exerts long-term effects on lung tissue and is an additional risk factor for the development of COPD. The presence of HCV is associated with an accelerated loss of lung function in COPD patients, especially in current smokers. COPD could represent extrahepatic manifestation associated with HCV infection. The aim of this article was to review the literature on prevalence of HCV in COPD and vice versa, pathogenetic link and the consequences of their mutual existence. |
topic |
COPD hepatitis C HCV comorbidity |
url |
http://www.degruyter.com/view/j/folmed.2017.59.issue-2/folmed-2017-0018/folmed-2017-0018.xml?format=INT |
work_keys_str_mv |
AT mekovevgeniv chronicobstructivepulmonarydiseaseandhepatitisc AT petkovrosene chronicobstructivepulmonarydiseaseandhepatitisc AT kostadinovdimitart chronicobstructivepulmonarydiseaseandhepatitisc AT antonovkrasimira chronicobstructivepulmonarydiseaseandhepatitisc AT jelevdeiant chronicobstructivepulmonarydiseaseandhepatitisc |
_version_ |
1726005206291841024 |